Dexa-BEAM

Indication

relapsed/refractory Hodgkin's disease

Regimen

Dexamethasone 8 mg tds PO Days 1-10
Carmustine 60 mg/m2 IV Day 2
Etoposide 75 mg/m2 IV Days 4-7
Ara-C 100 mg/m2 bd IV Days 4-7
Melphalan 20 mg/m2 IV Day 3

Repeat cycle every 28 days
Give 2 cycles before ASCT; if not for ASCT, give total 4 cycles 

References

Pfreundschuh MG et al. Dexa-BEAM in patients with Hodgkin's Disease refractory to multidrug chemotherapy regimens: A trial of the German Hodgkin's Disease Study Group. J Clin oncol 1994; 12:580